Medications

Rates of recurrent VTE compared for apixaban, rivaroxaban

(HealthDay)—For patients with venous thromboembolism (VTE), new users of apixaban have lower rates of recurrent VTE and bleeding compared with new users of rivaroxaban, according to a study published online Dec. 7 in the ...